文献速递白血病淋巴瘤

ETV6-NCOA2融合通过转化非胸腺造血祖细胞诱导T/髓系混合表型白血病

ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.
PubMed 文献 · Blood · 2022-01-01

该临床前研究探讨了ETV6-NCOA2融合基因在T/髓系混合表型急性白血病发生中的作用。小鼠骨髓造血祖细胞表达ETV6-NCOA2可诱导T/髓系淋巴瘤并伴自发Notch1激活突变;人脐血CD34+祖细胞共转染ETV6-NCOA2与未转化性NOTCH1突变体可在免疫缺陷鼠中诱导T/髓系白血病,表型与基因表达谱类似患者来源白血病。机制上ETV6-NCOA2与ETV6及组蛋白乙酰转移酶p300形成转录复合物,解除ETV6靶基因抑制。

要点

  • ETV6-NCOA2融合基因可在临床前模型中起始T/髓系混合表型白血病。
  • 非胸腺造血祖细胞中ETV6-NCOA2表达导致转录失调,激活淋系程序但未能抑制髓系基因如CSF1和MEF2C。
  • 获得性NOTCH1激活突变可将早期未成熟ETV6-NCOA2细胞转化为T/髓系白血病。

核心结论

  • ETV6-NCOA2通过转化非胸腺造血祖细胞并需额外NOTCH1激活突变来起始T/髓系白血病。

研究设计与样本

  • 临床前研究:小鼠骨髓造血祖细胞异位表达ETV6-NCOA2;人脐血CD34+祖细胞共转染ETV6-NCOA2与未转化性NOTCH1突变体后移植免疫缺陷鼠。

主要发现

  • 小鼠骨髓祖细胞表达ETV6-NCOA2诱导T/髓系淋巴瘤,伴自发Notch1激活突变。
  • 人CD34+祖细胞共转染ETV6-NCOA2与NOTCH1突变体在免疫缺陷鼠中诱导T/髓系白血病,免疫表型和基因表达模式类似患者来源ETV6-NCOA2白血病。
  • ETV6-NCOA2与ETV6及p300形成转录复合物,解除ETV6靶基因抑制。
  • ETV6-NCOA2表达激活淋系程序但未能抑制髓系基因CSF1和MEF2C,导致早期未成熟T细胞发育阶段阻滞。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mixed-phenotype acute leukemia is a rare subtype of leukemia in which both myeloid and lymphoid markers are co-expressed on the same malignant cells. The pathogenesis is largely unknown, and the treatment is challenging. We previously reported the specific association of the recurrent t(8;12)(q13;p13) chromosomal translocation that creates the ETV6-NCOA2 fusion with T/myeloid leukemias. Here we report that ETV6-NCOA2 initiates T/myeloid leukemia in preclinical models; ectopic expression of ETV6-NCOA2 in mouse bone marrow hematopoietic progenitors induced T/myeloid lymphoma accompanied by spontaneous Notch1-activating mutations. Similarly, cotransduction of human cord blood CD34+ progenitors with ETV6-NCOA2 and a nontransforming NOTCH1 mutant induced T/myeloid leukemia in immunodeficient mice; the immunophenotype and gene expression pattern were similar to those of patient-derived ETV6-NCOA2 leukemias. Mechanistically, we show that ETV6-NCOA2 forms a transcriptional complex with ETV6 and the histone acetyltransferase p300, leading to derepression of ETV6 target genes. The expression of ETV6-NCOA2 in human and mouse nonthymic hematopoietic progenitor cells induces transcriptional dysregulation, which activates a lymphoid program while failing to repress the expression of myeloid genes such as CSF1 and MEF2C. The ETV6-NCOA2 induced arrest at an early immature T-cell developmental stage. The additional acquisition of activating NOTCH1 mutations transforms the early immature ETV6-NCOA2 cells into T/myeloid leukemias. Here, we describe the first preclinical model to depict the initiation of T/myeloid leukemia by a specific somatic genetic aberration.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Fishman H, Madiwale S, Geron I, et al. ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells. Blood. 2022. PMID: 34624096. doi:10.1182/blood.2020010405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。